Log In
Print
BCIQ
Print
Print this Print this
 

PBI-4419

  Manage Alerts
Collapse Summary General Information
Company ProMetic Life Sciences Inc.
DescriptionOrally active third generation analog of PBI-1402, a chemoprotective activator of neutrophils
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today